Statistics for 4basebio PLC (id:3942 4BB)

Valuation metrics

Market cap

205.08M

Enterprise value

182.45M

Trailing P/E (ttm)

-2,096.77

Forward P/E

-0.22

PEG ratio

-0.22

Price/Sales (ttm)

344.09

Price/Book (mrq)

Enterprise Value/Revenue

306.12

Enterprise Value/EBITDA

-18.94

Overview

Shares outstanding

15.48M

Float

4.90M

Shares short

% Held by insiders

0.60%

% Held by institutions

0.15%

Average volume (10 days)

48.50K

Average volume (90 days)

Price summary

52-Week low

520.00

52-Week high

1.82K

52-Week change

58.08%

Beta

1.13

50-Day moving average

1.35K

200-Day moving average

1.26K

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

67.19%

Operating margin

-1,767.99%

Operational effectiveness

Return on assets

-54.30%

Return on equity

1.56K%

Income statement

Revenue (ttm)

0.05

Revenue per share (ttm)

0.05

Quarterly revenue growth (yoy)

Gross profit (ttm)

340.00K

EBITDA

-9,633,000.00

Net income to common (ttm)

-9,838,000.00

Diluted EPS (ttm)

-0.78

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.72M

Total cash per share (mrq)

0.21

Total debt (mrq)

15.49M

Total Debt/Equity (mrq)

-31.49

Current ratio (mrq)

272.70%

Book value per share (mrq)

-0.41

Cash flow

Cash flow statement

-8,332,000.00

Levered free cash flow (LFCF)

-7,063,500.00